C-Path Initiative's Work on Personalized Medicine Starts to Get Results

The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to advance personalized medicine, is advancing quickly and is bearing results, reports The Arizona Star.

share
Facebook